Business Information
The group's principal activity is to provide services to organizations involved in the drug discovery and development business. These services are organized into two segments: information services and contract study services. The information services segment is based on the group's gene expression reference database, the geneexpress system, for research related to drug discovery and optimization. The contract study services business consists of services related to drug development, including primarily preclinical toxicity and pharmacology studies and related laboratory services and, to a lesser extent, phase i clinical trial services. Geneexpress(R), toxexpress(R) bioexpresstm, ascentatm, genesistm enterprise system and genechip(R) are the registered trademarks of the group. The customers of the group include pharmaceutical and biotechnology companies and U.S. Government agencies. The group acquired therimmune research corporation on 01-arp-2003.
|
|
Name |
Title
|
Email
|
| Stark Thompson | Chmn. | N/A | | Louis Tartaglia | Chief Scientific Officer | N/A | | Philip Rohrer | CFO | N/A | | Albert Risdorfer | VP - Human Resources | Available | | Dudley Staples | Sr. VP, Sec., General Counsel | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 24,346 | (54,710) | | 2005 | 79,370 | (48,304) | | 2004 | 75,937 | (28,520)
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
